Clinical Trial Update: Pupillary Unrest as an Indicator of Central Opioid Effect in Subjects 40-60 Years of Age [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial assessing pupillary unrest as an indicator of central opioid effect in adults aged 40-60 has completed. Results were posted on 2025-0…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Toxicity
• Respiratory Depression

Snippet

Sponsor: University of California, San Francisco | Conditions: Opioid Toxicity, Pupillary Miosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-05-02